123 related articles for article (PubMed ID: 24525074)
1. Regulation of the cancer cell membrane lipid composition by NaCHOleate: effects on cell signaling and therapeutical relevance in glioma.
Lladó V; López DJ; Ibarguren M; Alonso M; Soriano JB; Escribá PV; Busquets X
Biochim Biophys Acta; 2014 Jun; 1838(6):1619-27. PubMed ID: 24525074
[TBL] [Abstract][Full Text] [Related]
2. Differential effect of 2-hydroxyoleic acid enantiomers on protein (sphingomyelin synthase) and lipid (membrane) targets.
Piotto S; Concilio S; Bianchino E; Iannelli P; López DJ; Terés S; Ibarguren M; Barceló-Coblijn G; Martin ML; Guardiola-Serrano F; Alonso-Sande M; Funari SS; Busquets X; Escribá PV
Biochim Biophys Acta; 2014 Jun; 1838(6):1628-37. PubMed ID: 24412218
[TBL] [Abstract][Full Text] [Related]
3. 2-Hydroxyoleate, a nontoxic membrane binding anticancer drug, induces glioma cell differentiation and autophagy.
Terés S; Lladó V; Higuera M; Barceló-Coblijn G; Martin ML; Noguera-Salvà MA; Marcilla-Etxenike A; García-Verdugo JM; Soriano-Navarro M; Saus C; Gómez-Pinedo U; Busquets X; Escribá PV
Proc Natl Acad Sci U S A; 2012 May; 109(22):8489-94. PubMed ID: 22586083
[TBL] [Abstract][Full Text] [Related]
4. Sphingomyelin and sphingomyelin synthase (SMS) in the malignant transformation of glioma cells and in 2-hydroxyoleic acid therapy.
Barceló-Coblijn G; Martin ML; de Almeida RF; Noguera-Salvà MA; Marcilla-Etxenike A; Guardiola-Serrano F; Lüth A; Kleuser B; Halver JE; Escribá PV
Proc Natl Acad Sci U S A; 2011 Dec; 108(49):19569-74. PubMed ID: 22106271
[TBL] [Abstract][Full Text] [Related]
5. The role of membrane fatty acid remodeling in the antitumor mechanism of action of 2-hydroxyoleic acid.
Martin ML; Barceló-Coblijn G; de Almeida RF; Noguera-Salvà MA; Terés S; Higuera M; Liebisch G; Schmitz G; Busquets X; Escribá PV
Biochim Biophys Acta; 2013 May; 1828(5):1405-13. PubMed ID: 23360770
[TBL] [Abstract][Full Text] [Related]
6. The effect of hydroxylated fatty acid-containing phospholipids in the remodeling of lipid membranes.
Piotto S; Trapani A; Bianchino E; Ibarguren M; López DJ; Busquets X; Concilio S
Biochim Biophys Acta; 2014 Jun; 1838(6):1509-17. PubMed ID: 24463068
[TBL] [Abstract][Full Text] [Related]
7. Normalization of sphingomyelin levels by 2-hydroxyoleic acid induces autophagic cell death of SF767 cancer cells.
Terés S; Lladó V; Higuera M; Barceló-Coblijn G; Martin ML; Noguera-Salvà MA; Marcilla-Etxenike A; García-Verdugo JM; Soriano-Navarro M; Saus C; Gómez-Pinedo U; Busquets X; Escribá PV
Autophagy; 2012 Oct; 8(10):1542-4. PubMed ID: 22892762
[TBL] [Abstract][Full Text] [Related]
8. Effects of 2-hydroxyoleic acid on the structural properties of biological and model plasma membranes.
Prades J; Alemany R; Perona JS; Funari SS; Vögler O; Ruiz-Gutiérrez V; Escribá PV; Barceló F
Mol Membr Biol; 2008 Jan; 25(1):46-57. PubMed ID: 17852735
[TBL] [Abstract][Full Text] [Related]
9. Partitioning of liquid-ordered/liquid-disordered membrane microdomains induced by the fluidifying effect of 2-hydroxylated fatty acid derivatives.
Ibarguren M; López DJ; Encinar JA; González-Ros JM; Busquets X; Escribá PV
Biochim Biophys Acta; 2013 Nov; 1828(11):2553-63. PubMed ID: 23792066
[TBL] [Abstract][Full Text] [Related]
10. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
11. Minerval (2-hydroxyoleic acid) causes cancer cell selective toxicity by uncoupling oxidative phosphorylation and compromising bioenergetic compensation capacity.
Massalha W; Markovits M; Pichinuk E; Feinstein-Rotkopf Y; Tarshish M; Mishra K; Llado V; Weil M; Escriba PV; Kakhlon O
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30602451
[TBL] [Abstract][Full Text] [Related]
12. 2-Hydroxyoleic acid induces ER stress and autophagy in various human glioma cell lines.
Marcilla-Etxenike A; Martín ML; Noguera-Salvà MA; García-Verdugo JM; Soriano-Navarro M; Dey I; Escribá PV; Busquets X
PLoS One; 2012; 7(10):e48235. PubMed ID: 23133576
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of sphingomyelin synthase (SMS) affects intracellular sphingomyelin accumulation and plasma membrane lipid organization.
Li Z; Hailemariam TK; Zhou H; Li Y; Duckworth DC; Peake DA; Zhang Y; Kuo MS; Cao G; Jiang XC
Biochim Biophys Acta; 2007 Sep; 1771(9):1186-94. PubMed ID: 17616479
[TBL] [Abstract][Full Text] [Related]
14. The anti-tumor drug 2-hydroxyoleic acid (Minerval) stimulates signaling and retrograde transport.
Torgersen ML; Klokk TI; Kavaliauskiene S; Klose C; Simons K; Skotland T; Sandvig K
Oncotarget; 2016 Dec; 7(52):86871-86888. PubMed ID: 27894086
[TBL] [Abstract][Full Text] [Related]
15. Membrane structure modulation, protein kinase C alpha activation, and anticancer activity of minerval.
Martínez J; Vögler O; Casas J; Barceló F; Alemany R; Prades J; Nagy T; Baamonde C; Kasprzyk PG; Terés S; Saus C; Escribá PV
Mol Pharmacol; 2005 Feb; 67(2):531-40. PubMed ID: 15531732
[TBL] [Abstract][Full Text] [Related]
16. The repression of E2F-1 is critical for the activity of Minerval against cancer.
Martínez J; Gutiérrez A; Casas J; Lladó V; López-Bellan A; Besalduch J; Dopazo A; Escribá PV
J Pharmacol Exp Ther; 2005 Oct; 315(1):466-74. PubMed ID: 16027227
[TBL] [Abstract][Full Text] [Related]
17. Diacylglycerol molecular species in plasma membrane and microsomes change transiently with endothelin-1 treatment of glioma cells.
Laurin DE; Byers DM; Palmer FB; Cook HW
Prostaglandins Other Lipid Mediat; 1998 Mar; 55(4):189-207. PubMed ID: 9644111
[TBL] [Abstract][Full Text] [Related]
18. NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells.
Yu Z; Xie G; Zhou G; Cheng Y; Zhang G; Yao G; Chen Y; Li Y; Zhao G
Cancer Lett; 2015 Oct; 367(1):58-68. PubMed ID: 26188279
[TBL] [Abstract][Full Text] [Related]
19. Boswellic acids and malignant glioma: induction of apoptosis but no modulation of drug sensitivity.
Glaser T; Winter S; Groscurth P; Safayhi H; Sailer ER; Ammon HP; Schabet M; Weller M
Br J Cancer; 1999 May; 80(5-6):756-65. PubMed ID: 10360653
[TBL] [Abstract][Full Text] [Related]
20. Resistance to small molecule inhibitors of epidermal growth factor receptor in malignant gliomas.
Li B; Chang CM; Yuan M; McKenna WG; Shu HK
Cancer Res; 2003 Nov; 63(21):7443-50. PubMed ID: 14612544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
